8/12/2024 | HC Wainwright | Reiterated Rating | Buy ➝ Buy | $32.00 ➝ $32.00 | |
7/29/2024 | Piper Sandler | Downgrade | Overweight ➝ Neutral | $19.00 ➝ $10.00 | |
6/28/2024 | HC Wainwright | Reiterated Rating | Buy ➝ Buy | $32.00 ➝ $32.00 | |
6/20/2024 | JMP Securities | Lower Target | Market Outperform ➝ Market Outperform | $25.00 ➝ $23.00 | |
5/31/2024 | HC Wainwright | Reiterated Rating | Buy ➝ Buy | $32.00 ➝ $32.00 | |
5/24/2024 | HC Wainwright | Reiterated Rating | Buy ➝ Buy | $32.00 ➝ $32.00 | |
5/10/2024 | HC Wainwright | Reiterated Rating | Buy ➝ Buy | $32.00 | |
3/14/2024 | Piper Sandler | Boost Target | Overweight ➝ Overweight | $18.00 ➝ $19.00 | |
3/1/2024 | Wells Fargo & Company | Boost Target | Overweight ➝ Overweight | $22.00 ➝ $25.00 | |
2/29/2024 | HC Wainwright | Reiterated Rating | Buy ➝ Buy | $32.00 | |
2/29/2024 | The Goldman Sachs Group | Boost Target | Buy ➝ Buy | $19.00 ➝ $21.00 | |
2/29/2024 | Barclays | Boost Target | Overweight ➝ Overweight | $18.00 ➝ $22.00 | |
2/20/2024 | JMP Securities | Boost Target | Market Outperform ➝ Market Outperform | $18.00 ➝ $25.00 | |
2/20/2024 | Wells Fargo & Company | Boost Target | Overweight ➝ Overweight | $17.00 ➝ $22.00 | |
2/20/2024 | Piper Sandler | Boost Target | Overweight ➝ Overweight | $14.00 ➝ $18.00 | |
2/20/2024 | The Goldman Sachs Group | Boost Target | Buy ➝ Buy | $13.00 ➝ $19.00 | |
2/20/2024 | Chardan Capital | Boost Target | Buy ➝ Buy | $29.00 ➝ $34.00 | |
12/27/2023 | HC Wainwright | Lower Target | Buy ➝ Buy | $38.00 ➝ $28.00 | |
12/27/2023 | Truist Financial | Reiterated Rating | Buy ➝ Buy | $17.00 | |
11/20/2023 | The Goldman Sachs Group | Initiated Coverage | Buy | $12.00 | |
11/7/2023 | HC Wainwright | Lower Target | Buy ➝ Buy | $38.00 ➝ $28.00 | |
9/18/2023 | Barclays | Lower Target | Overweight ➝ Overweight | $40.00 ➝ $18.00 | |
9/15/2023 | HC Wainwright | Reiterated Rating | Buy ➝ Buy | $38.00 | |
9/15/2023 | JMP Securities | Reiterated Rating | Market Outperform ➝ Market Outperform | $18.00 | |
9/15/2023 | Mizuho | Reiterated Rating | Buy ➝ Buy | $30.00 | |
9/15/2023 | Truist Financial | Reiterated Rating | Buy ➝ Buy | $17.00 | |
9/13/2023 | Stifel Nicolaus | Lower Target | Buy ➝ Buy | $27.00 ➝ $26.00 | |
8/17/2023 | JMP Securities | Reiterated Rating | Market Outperform ➝ Market Outperform | $18.00 | |
8/16/2023 | Chardan Capital | Reiterated Rating | Buy ➝ Buy | $29.00 | |
8/9/2023 | HC Wainwright | Reiterated Rating | Buy ➝ Buy | $38.00 | |
8/9/2023 | Chardan Capital | Reiterated Rating | Buy ➝ Buy | $29.00 | |
8/9/2023 | Robert W. Baird | Lower Target | | $23.00 ➝ $20.00 | |
5/30/2023 | Wells Fargo & Company | Upgrade | Equal Weight ➝ Overweight | $11.00 ➝ $17.00 | |
5/30/2023 | Stifel Nicolaus | Boost Target | | $21.00 ➝ $24.00 | |
5/23/2023 | Robert W. Baird | Boost Target | | $20.00 ➝ $23.00 | |
5/10/2023 | Robert W. Baird | Lower Target | | $25.00 ➝ $20.00 | |
3/27/2023 | Wells Fargo & Company | Reiterated Rating | Equal Weight | $11.00 | |
3/6/2023 | Wells Fargo & Company | Lower Target | Equal Weight | $14.00 ➝ $11.00 | |
3/1/2023 | HC Wainwright | Reiterated Rating | Buy | $38.00 | |
3/1/2023 | Chardan Capital | Reiterated Rating | Buy | $29.00 | |
3/1/2023 | Oppenheimer | Lower Target | Outperform | $25.00 ➝ $15.00 | |
1/27/2023 | Piper Sandler | Upgrade | Neutral ➝ Overweight | $11.00 ➝ $14.00 | |
1/24/2023 | Truist Financial | Boost Target | Buy | $16.00 ➝ $17.00 | |
12/9/2022 | Benchmark | Downgrade | Neutral | $20.00 ➝ $6.00 | |
12/8/2022 | The Goldman Sachs Group | Downgrade | Buy ➝ Neutral | $20.00 ➝ $6.00 | |
11/21/2022 | JMP Securities | Lower Target | Market Outperform | $25.00 ➝ $21.00 | |
11/20/2022 | Piper Sandler | Lower Target | Neutral | $13.00 ➝ $11.00 | |
11/18/2022 | Chardan Capital | Lower Target | Buy | $30.00 ➝ $29.00 | |
11/18/2022 | Oppenheimer | Lower Target | | $27.00 ➝ $25.00 | |
11/18/2022 | HC Wainwright | Lower Target | Buy | $43.00 ➝ $38.00 | |
10/31/2022 | Guggenheim | Initiated Coverage | Neutral | | |
9/12/2022 | JMP Securities | Reiterated Rating | Buy | $25.00 | |
8/23/2022 | Truist Financial | Lower Target | | $18.00 | |
8/18/2022 | Wells Fargo & Company | Reiterated Rating | Equal Weight | $14.00 | |
8/5/2022 | Chardan Capital | Lower Target | | $31.00 ➝ $30.00 | |
8/5/2022 | Robert W. Baird | Lower Target | Outperform | $34.00 ➝ $25.00 | |
7/1/2022 | The Goldman Sachs Group | Lower Target | Buy | $64.00 ➝ $18.00 | |
6/8/2022 | JMP Securities | Reiterated Rating | Buy | $25.00 | |
5/27/2022 | Truist Financial | Lower Target | | $20.00 | |
5/27/2022 | Oppenheimer | Lower Target | Outperform | $31.00 ➝ $27.00 | |
5/27/2022 | Chardan Capital | Lower Target | Buy | $44.00 ➝ $31.00 | |
5/27/2022 | Piper Sandler | Lower Target | Neutral | $20.00 ➝ $13.00 | |
5/24/2022 | The Goldman Sachs Group | Lower Target | Buy | $79.00 ➝ $64.00 | |
4/7/2022 | Truist Financial | Lower Target | | $32.00 ➝ $29.00 | |
4/7/2022 | Robert W. Baird | Boost Target | Outperform | $30.00 ➝ $34.00 | |
2/28/2022 | Truist Financial | Lower Target | | $45.00 ➝ $32.00 | |
2/25/2022 | Chardan Capital | Lower Target | Buy | $50.00 ➝ $45.00 | |
2/25/2022 | Robert W. Baird | Lower Target | Outperform | $35.00 ➝ $30.00 | |
1/28/2022 | Stifel Nicolaus | Upgrade | Hold ➝ Buy | $23.00 ➝ $25.00 | |
1/5/2022 | Wells Fargo & Company | Lower Target | | $35.00 ➝ $25.00 | |
12/7/2021 | Cowen | Initiated Coverage | Outperform | | |
11/15/2021 | Oppenheimer | Lower Target | Outperform | $38.00 ➝ $31.00 | |
11/5/2021 | HC Wainwright | Lower Target | Buy | $46.00 ➝ $43.00 | |
11/5/2021 | Piper Sandler | Boost Target | Neutral | $18.00 ➝ $20.00 | |
8/24/2021 | Robert W. Baird | Reiterated Rating | Buy | $35.00 | |
8/11/2021 | JMP Securities | Reiterated Rating | Buy | | |
7/7/2021 | Chardan Capital | Reiterated Rating | Buy | | |
6/29/2021 | Mizuho | Initiated Coverage | Buy | $30.00 | |
6/29/2021 | Chardan Capital | Reiterated Rating | Buy | $51.00 | |
6/10/2021 | JMP Securities | Upgrade | Market Perform ➝ Outperform | $32.00 | |
5/26/2021 | Piper Sandler | Reiterated Rating | Overweight ➝ Neutral | $35.00 ➝ $18.00 | |
5/25/2021 | Oppenheimer | Lower Target | Outperform | $51.00 ➝ $38.00 | |
5/20/2021 | Robert W. Baird | Lower Target | Outperform | $55.00 ➝ $35.00 | |
5/20/2021 | Mizuho | Boost Target | Buy | $30.00 ➝ $55.00 | |
5/20/2021 | Piper Sandler | Downgrade | Overweight ➝ Neutral | $35.00 ➝ $18.00 | |
5/19/2021 | Stifel Nicolaus | Downgrade | Buy ➝ Hold | | |
5/19/2021 | Chardan Capital | Lower Target | Buy | $54.00 ➝ $51.00 | |
5/19/2021 | Oppenheimer | Lower Target | Outperform | $57.00 ➝ $51.00 | |
5/19/2021 | JMP Securities | Lower Target | Outperform ➝ Market Perform | $45.00 ➝ $43.00 | |
5/19/2021 | Barclays | Lower Target | Overweight | $60.00 ➝ $40.00 | |
5/19/2021 | HC Wainwright | Lower Target | Buy | $50.00 ➝ $46.00 | |
5/19/2021 | Piper Sandler | Lower Target | Overweight | $45.00 ➝ $35.00 | |
5/3/2021 | Truist Financial | Initiated Coverage | Buy | $50.00 | |
4/16/2021 | The Goldman Sachs Group | Initiated Coverage | Buy | | |
3/8/2021 | HC Wainwright | Upgrade | Neutral ➝ Buy | $50.00 | |
3/1/2021 | Chardan Capital | Reiterated Rating | Buy | | |
1/14/2021 | Oppenheimer | Boost Target | Outperform | $43.00 ➝ $57.00 | |
12/17/2020 | Barclays | Boost Target | Positive ➝ Overweight | $43.00 ➝ $55.00 | |
12/15/2020 | HC Wainwright | Downgrade | Buy ➝ Neutral | | |
11/9/2020 | JMP Securities | Boost Target | Market Outperform | $38.00 ➝ $45.00 | |
11/6/2020 | Barclays | Boost Target | Overweight | $36.00 ➝ $43.00 | |
11/6/2020 | Piper Sandler | Boost Target | Overweight | $35.00 ➝ $45.00 | |
10/15/2020 | Wells Fargo & Company | Boost Target | Equal Weight ➝ Equal Weight | $29.00 ➝ $35.00 | |
10/6/2020 | Stifel Nicolaus | Lower Target | | $47.00 ➝ $42.00 | |
10/6/2020 | Barclays | Lower Target | Overweight | $45.00 ➝ $36.00 | |
10/6/2020 | HC Wainwright | Lower Target | Buy | $48.00 ➝ $46.00 | |
10/6/2020 | Wells Fargo & Company | Downgrade | Overweight ➝ Equal Weight | $49.00 ➝ $29.00 | |
10/6/2020 | Oppenheimer | Reiterated Rating | Buy | $43.00 | |
10/6/2020 | Chardan Capital | Reiterated Rating | Buy | $53.00 ➝ $50.00 | |
8/7/2020 | Chardan Capital | Boost Target | Buy | $44.00 ➝ $53.00 | |
8/7/2020 | Oppenheimer | Reiterated Rating | Buy | $43.00 | |
6/15/2020 | Oppenheimer | Initiated Coverage | Buy | $43.00 | |
5/28/2020 | Stifel Nicolaus | Boost Target | Buy | $48.00 ➝ $50.00 | |
5/27/2020 | Chardan Capital | Reiterated Rating | Buy | | |
5/14/2020 | Chardan Capital | Reiterated Rating | Buy | $44.00 | |
5/6/2020 | Robert W. Baird | Boost Target | Outperform | $60.00 ➝ $65.00 | |
5/5/2020 | Oppenheimer | Initiated Coverage | Buy | $43.00 | |
5/5/2020 | Mizuho | Reiterated Rating | Buy | $61.00 | |
4/29/2020 | HC Wainwright | Boost Target | Positive ➝ Buy | $36.00 ➝ $48.00 | |
4/28/2020 | Oppenheimer | Initiated Coverage | Buy | $35.00 ➝ $43.00 | |
4/27/2020 | Chardan Capital | Boost Target | Buy | $36.00 ➝ $44.00 | |
4/27/2020 | Mizuho | Reiterated Rating | Buy | $61.00 | |
4/21/2020 | Mizuho | Initiated Coverage | Buy | | |
3/4/2020 | Barclays | Initiated Coverage | Overweight | $45.00 | |
2/26/2020 | Piper Sandler | Boost Target | Outperform | $40.00 | |
2/26/2020 | Chardan Capital | Reiterated Rating | Buy | $36.00 | |
2/26/2020 | Oppenheimer | Reiterated Rating | Outperform | $32.00 ➝ $35.00 | |
2/26/2020 | Cowen | Reiterated Rating | Buy | | |
2/26/2020 | HC Wainwright | Boost Target | Buy | $32.00 ➝ $36.00 | |
2/26/2020 | Wells Fargo & Company | Boost Target | Overweight | $32.00 ➝ $38.00 | |
1/13/2020 | Cowen | Initiated Coverage | Buy | | |
12/18/2019 | JMP Securities | Initiated Coverage | Outperform | $38.00 | |
11/21/2019 | HC Wainwright | Reiterated Rating | Buy | $32.00 | |
11/21/2019 | Chardan Capital | Reiterated Rating | Buy | $33.00 | |
11/8/2019 | Chardan Capital | Reiterated Rating | Buy | $33.00 | |
11/5/2019 | HC Wainwright | Reiterated Rating | Buy | $32.00 | |